Media coverage about Cellular Dynamics International (NASDAQ:ICEL) has been trending somewhat positive this week, according to Accern. Accern rates the sentiment of press coverage by monitoring more than twenty million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Cellular Dynamics International earned a news sentiment score of 0.16 on Accern’s scale. Accern also gave news headlines about the company an impact score of 43.8400817010205 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.

Shares of Cellular Dynamics International (NASDAQ ICEL) opened at 16 on Friday. Cellular Dynamics International has a 1-year low of $5.00 and a 1-year high of $17.00. The firm has a 50-day moving average of $14.00 and a 200-day moving average of $8.00.

COPYRIGHT VIOLATION WARNING: “Cellular Dynamics International (ICEL) Given Coverage Optimism Rating of 0.16” was originally reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this article on another site, it was copied illegally and republished in violation of international trademark & copyright law. The original version of this article can be accessed at

About Cellular Dynamics International

Cellular Dynamics International, Inc develops and produces functioning human cells in industrial quantities. The Company’s products include true human cells in multiple cell types (iCell products), human induced pluripotent stem cells (iPSCs) and custom iPSCs and iCell products (MyCell products). It markets its products for use in life science in vitro research and development, as well as applied product testing, stem cell banking and in vivo cellular therapeutics.

Receive News & Stock Ratings for Cellular Dynamics International Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cellular Dynamics International Inc and related stocks with our FREE daily email newsletter.